Vision RT Celebrates Two Queens Awards

Vision RT, a global leader in surface guided radiotherapy cancer treatment, has received a Queen’s award for Enterprise for both International Trade and for Innovation. The awards were presented by Leslie Morgan OBE, Deputy Lieutenant of the Greater London Lieutenancy, being one of six British companies to receive a double accolade at the Queen’s 90^th birthday awards in 2016. Vision RT’s technology tracks the patient’s position in 3D before and during radiation therapy, helping clinical users deliver radiation safely, efficiently and comfortably.

Started in 2001 by CEO Dr Norman Smith, together with CTO Dr Ivan Meir and Mr Peter Kalm, initial prototype systems were installed around London and at Massachusetts General Hospital, one of the top cancer centres in the USA. Successful installment of systems world-wide, led to the signing of a “white-label” OEM agreement with Varian Medical Systems in October 2012. Today, over 700 systems using Vision RT’s technology have been sold to cancer clinics around the world.

Norman Smith, CEO of Vision RT said: “We are extremely proud of what Vision RT has achieved in the past 15 years. From a few engineers with an idea, we have become the global leader in surface guided radiotherapy, a field that is making treatments safer and more comfortable for patients and more economic and efficient for health systems. We are aiming for our technology to become the standard of care and to benefit every patient in every clinic around the world. With rapid clinical adoption and growth of our business in recent years, these are very exciting times for Vision RT.”